November 11, 2015November 11, 2015

Mantle Cell Lymphoma Combination Therapy of Lenalidomide and Rituximab Shows Promise in New Study

News

A combination therapy of the immunomodulatory drug lenalidomide together with rituximab, an anti-CD20 antibody, in patients with mantle-cell lymphoma has shown positive responses from most participants in a clinical trial. The report entitled “Lenalidomide plus ... Read more

October 14, 2015October 15, 2015

Q Fever Bacterium Might Contribute to Non-Hodgkin Lymphoma Development

News

A new research study reports on the correlation between infection with Coxiella burnetii, the bacterium that causes Q fever, and an increased risk of lymphoma development. The study, entitled “B-cell ... Read more